Proteomic and metabolomic biomarkers of Alzheimer’s disease: Opportunities to advance precision medicine and clinical trials
Proteomic and metabolomic methodologies In the general AD population, proteomic and metabolomic studies are under close scrutiny as inconsistency in outcomes and variability in preanalytic methods (sample collection, processing, storage,…